share_log

BMO Capital Maintains Outperform on Nuvalent, Raises Price Target to $79

Benzinga ·  Oct 19, 2023 11:49

BMO Capital analyst Etzer Darout maintains Nuvalent (NASDAQ:NUVL) with a Outperform and raises the price target from $73 to $79.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment